Aromatic-rich C-terminal region of LCI is a potent antimicrobial peptide in itself

Biochem Biophys Res Commun. 2019 Nov 5;519(2):372-377. doi: 10.1016/j.bbrc.2019.09.013. Epub 2019 Sep 10.

Abstract

LCI is a 47-residue antimicrobial peptide produced by Bacillus subtilis. The peptide displays potent activity against plant pathogens, Xanthomonas and Pseudomonas. The peptide takes a compact 3-dimensional structure characterized by a four-stranded β-sheet. The peptide is unusually rich in aromatic residues; 10 of the 47 residues are aromatic and 8 of them lie in the C-terminal region, LCI22-47. Here we report the antimicrobial activity of this C-terminal region against Gram-positive and Gram-negative bacteria. The C-terminal-amidated peptide displays potent activity against E. coli, methicillin and gentamicin-resistant S. aureus, and Xanthomonas oryzae pv. oryzae with lethal concentrations ≤4 μM. Membrane-binding assays indicate preferential binding to the negatively-charged lipids. The peptide permeabilizes the outer-membrane of E. coli indicating membrane-permeabilization as one of the mechanisms of killing. Interestingly, however, no inner-membrane permeabilization was observed, indicating that the membrane-permeabilization may not be the sole mechanism of action.

Keywords: Antimicrobial; Fluorescence; LCI(22-47); Membrane; Peptide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemical synthesis
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology*
  • Antimicrobial Cationic Peptides / chemical synthesis
  • Antimicrobial Cationic Peptides / chemistry
  • Antimicrobial Cationic Peptides / pharmacology*
  • Bacterial Proteins / chemical synthesis
  • Bacterial Proteins / chemistry
  • Bacterial Proteins / pharmacology*
  • Dose-Response Relationship, Drug
  • Escherichia coli / drug effects*
  • Escherichia coli / growth & development
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Methicillin-Resistant Staphylococcus aureus / growth & development
  • Microbial Sensitivity Tests
  • Structure-Activity Relationship
  • Xanthomonas / drug effects*
  • Xanthomonas / growth & development

Substances

  • Anti-Bacterial Agents
  • Antimicrobial Cationic Peptides
  • Bacterial Proteins
  • LCI peptide, Bacillus subtilis

Supplementary concepts

  • Xanthomonas oryzae